伦敦的生物技术初创公司Baseimmune近日宣布，在A轮融资中成功筹集了1130万美元（900万英镑），以加速其用于简化疫苗设计的先进机器学习平台的开发。这家总部位于伦敦的公司，凭借其创新的AI技术，旨在改变疫苗研发的传统方式，为全球健康挑战提供更快、更有效的解决方案。
此次融资由MSD Global Health Innovation Fund领投，IQ Capital等投资者也参与了此次超额认购的融资。早期支持者包括Hoxton Ventures、Creator Fund、Beast Ventures和Maki.vc，这些投资者的持续支持显示出对Baseimmune技术潜力和市场前景的高度认可。
Baseimmune的机器学习平台利用人工智能设计疫苗，通过缩短开发周期，降低成本，有望显著提高疫苗的可及性和效力。这一平台的应用范围广泛，不仅限于传染病疫苗，未来还可能扩展到癌症免疫治疗等领域。
随着全球对疫苗和疾病预防解决方案的需求日益增长，Baseimmune的这一轮融资标志着AI技术在生物医学领域的应用迈出了重要一步。此次融资的成功，不仅为Baseimmune的研发工作提供了强大动力，也为全球公共卫生事业注入了新的希望。
英文翻译内容：
Title: London-based Biotech Startup Baseimmune Raises $11.3 Million in Series A Funding to Advance AI-driven Vaccine Design Platform
Keywords: AI-driven vaccine design, biotechnology startup, funding round, machine learning
News content:
London biotech startup Baseimmune has announced the successful raising of $11.3 million (£9 million) in Series A funding to accelerate the development of its innovative machine learning platform for simplifying vaccine design. Headquartered in London, the company aims to transform traditional vaccine development methods, offering faster and more effective solutions to global health challenges with its cutting-edge AI technology.
The oversubscribed funding round was led by MSD Global Health Innovation Fund, with participation from investors such as IQ Capital. Early supporters including Hoxton Ventures, Creator Fund, Beast Ventures, and Maki.vc have also reaffirmed their confidence in Baseimmune’s technology and market potential through continued support.
Baseimmune’s machine learning platform leverages AI to design vaccines, potentially缩短开发周期、降低成本， significantly improving vaccine accessibility and effectiveness. With applications ranging from infectious diseases to cancer immunotherapy, the platform’s scope is broad and its future expansion promising.
As global demand for vaccines and disease prevention solutions continues to grow, Baseimmune’s funding round marks an important step forward for the application of AI in the biomedical field. The successful funding not only provides a strong impetus for Baseimmune’s research and development but also injects new hope into global public health efforts.
【来源】https://www.maginative.com/article/baseimmune-closes-11-3m-series-a-to-accelerate-ai-designed-vaccines/
Views: 1